Hodgkins Lymphoma Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, and treatment and the support of other individuals being treated at some of the best cancer centers. Hodgkins Lymphoma Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
KEYNOTE trials demonstrate Keytruda immunotherapy is highly effective treatment of advanced-refractory Hodgkin Lymphoma
Adcetris + AVD and G-CSF significantly improves outcomes compared to ABVD - 4 years follow up.from ASH 2019.
Caring for Yourself During Chemotherapy for Hodgkin’s Lymphoma: How to Manage Hair Loss, Dry Skin, and Brittle Nails
HL: Be aware of longer term complications and issues.